EXACT SCIENCES CORP (EXAS) Forecast, Price Target & Analyst Ratings

NASDAQ:EXAS • US30063P1057

Current stock price

104.91 USD
+0.99 (+0.95%)
At close:
104.947 USD
+0.04 (+0.04%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXACT SCIENCES CORP (EXAS).

Forecast Snapshot

Consensus Price Target

Price Target
$104.35
-0.54% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
856.19M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
66.90%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$104.35
Upside
-0.54%
From current price of $104.91 to mean target of $104.35, Based on 29 analyst forecasts
Low
$78.78
Median
$107.10
High
$110.25

Price Target Revisions

1 Month
-1.08%
3 Months
3.68%

Price Target Summary

29 Wall Street analysts provided a forecast for the next 12 months for EXAS. The average price target is 104.35 USD. This implies a price decrease of -0.54% is expected in the next year compared to the current price of 104.91.
The average price target has been revised upward by 3.68% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

EXAS Current Analyst RatingEXAS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15 20

Analyst Ratings History

EXAS Historical Analyst RatingsEXAS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
66.90%
EXAS was analyzed by 29 analysts. The buy percentage consensus is at 67. So analysts seem to be have mildly positive about EXAS.
In the previous month the buy percentage consensus was at a similar level.
EXAS was analyzed by 29 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-20MizuhoDowngrade Outperform -> Neutral
2026-01-05Evercore ISI GroupDowngrade Outperform -> In-Line
2025-11-25Canaccord GenuityDowngrade Buy -> Hold
2025-11-24BenchmarkDowngrade Buy -> Hold
2025-11-24JefferiesDowngrade Buy -> Hold
2025-11-21GuggenheimDowngrade Buy -> Neutral
2025-11-21William BlairDowngrade Outperform -> Market Perform
2025-11-21BarclaysDowngrade Overweight -> Equal-Weight
2025-11-21Wells FargoDowngrade Overweight -> Equal-Weight
2025-11-20BTIGDowngrade Buy -> Neutral
2025-11-11Piper SandlerMaintains Overweight -> Overweight
2025-11-05Wells FargoMaintains Overweight -> Overweight
2025-11-04TD CowenMaintains Buy -> Buy
2025-11-04GuggenheimMaintains Buy -> Buy
2025-11-04BTIGMaintains Buy -> Buy
2025-11-04BenchmarkMaintains Buy -> Buy
2025-11-04StifelMaintains Buy -> Buy
2025-11-04BarclaysMaintains Overweight -> Overweight
2025-11-04BairdMaintains Outperform -> Outperform
2025-10-22BTIGMaintains Buy -> Buy
2025-10-08Piper SandlerMaintains Overweight -> Overweight
2025-10-07Evercore ISI GroupMaintains Outperform -> Outperform
2025-10-02BarclaysMaintains Overweight -> Overweight
2025-09-11Craig-HallumMaintains Buy -> Buy
2025-08-12BTIGMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
856.19M
Revenue Q2Q
21.14%
EPS Q2Q
72.61%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
0.75%
Revenue (3 Months)
1.07%
EPS (1 Month)
21.62%
EPS (3 Months)
23.68%

Next Earnings Summary

EXAS is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is -0.15 USD and the consensus revenue estimate is 856.19M USD.
The next earnings revenue estimate has been revised upward by 1.07% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
EXAS revenue by date.EXAS revenue by date.
2.5B
19.93%		2.759B
10.37%		3.247B
17.69%		3.744B
15.31%		4.207B
12.37%		4.539B
7.89%		4.807B
5.90%		5.227B
8.74%		4.537B
-13.20%		4.662B
2.76%		4.789B
2.72%
EBITDA
YoY % growth
EXAS ebitda by date.EXAS ebitda by date.
-7.783M
97.95%		35.616M
557.61%		22.481M
-36.88%		620.38M
2,659.57%		823.71M
32.78%		1.055B
28.08%		1.313B
24.45%		1.507B
14.78%		1.709B
13.40%		1.868B
9.30%		1.913B
2.41%
EBIT
YoY % growth
EXAS ebit by date.EXAS ebit by date.
-214.391M
62.88%		-179.243M
16.39%		-199.098M
-11.08%		95.076M
147.75%		302.42M
218.08%		522.34M
72.72%		708.71M
35.68%		1.073B
51.40%		1.337B
24.60%		1.622B
21.32%		1.852B
14.18%
Operating Margin
EXAS operating margin by date.EXAS operating margin by date.
-8.58%-6.50%-6.13%2.54%7.19%11.51%14.74%20.53%29.47%34.79%38.67%
EPS
YoY % growth
EXAS eps by date.EXAS eps by date.
-1.14
66.76%		-5.57
-388.60%		-1.03
81.51%		0.30
129.51%		1.25
309.82%		1.91
53.29%		3.76
97.12%		3.87
2.71%		5.23
35.36%		5.94
13.45%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.15
72.61%		0.13
1,375.00%		0.16
258.10%		0.16
141.61%		-0.02
86.21%		0.38
196.00%		0.31
93.55%		0.36
125.81%		0.05
350.00%		0.50
32.43%		0.46
50.00%		0.57
60.00%
Revenue
Q2Q % growth		856.19M
21.14%		938.86M
15.75%		979.62M
15.15%		995.24M
13.30%		939.32M
9.71%		1.018B
8.43%		1.081B
10.35%		1.086B
9.12%		1.008B
7.31%		1.102B
8.25%		1.18B
9.16%		1.196B
10.13%
EBITDA
Q2Q % growth		115.14M
422.54%		175.06M
63.31%		183.58M
30.92%		181.34M
30.10%		150.86M
31.02%		230.11M
31.45%		212.77M
15.90%		225.52M
24.36%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-30.413M
66.12%		34.451M
1,703.86%		51.625M
306.48%		32.249M
139.24%		6.324M
120.79%		85.17M
147.22%		71.196M
37.91%		81.294M
152.08%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EXAS Yearly Revenue VS EstimatesEXAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B 5B
EXAS Yearly EPS VS EstimatesEXAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
56.78%
EPS Next 5 Year
41.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.28%
Revenue Next 5 Year
9.67%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
123.48%
EBIT Next 5 Year
72.07%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

EXACT SCIENCES CORP / EXAS Forecast FAQ

What is the price target for EXAS stock?

29 analysts have analysed EXAS and the average price target is 104.35 USD. This implies a price decrease of -0.54% is expected in the next year compared to the current price of 104.91.

When does EXACT SCIENCES CORP (EXAS) report earnings?

EXACT SCIENCES CORP (EXAS) will report earnings on 2026-04-29, after the market close.

Can you provide the consensus estimates for EXACT SCIENCES CORP next earnings?

The consensus EPS estimate for the next earnings of EXACT SCIENCES CORP (EXAS) is -0.15 USD and the consensus revenue estimate is 856.19M USD.

Can you provide the consensus rating for EXACT SCIENCES CORP stock?

The consensus rating for EXACT SCIENCES CORP (EXAS) is 66.8966 / 100 . This indicates that analysts generally have a neutral outlook on the stock.